Nitric oxide and peroxynitrite in health and disease P Pacher, JS Beckman, L Liaudet Physiological reviews 87 (1), 315-424, 2007 | 7631 | 2007 |
The endocannabinoid system as an emerging target of pharmacotherapy P Pacher, S Bátkai, G Kunos Pharmacological reviews 58 (3), 389-462, 2006 | 2628 | 2006 |
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol PAL Pacher, A Nivorozhkin, C Szabó Pharmacological reviews 58 (1), 87-114, 2006 | 1518 | 2006 |
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases G Haskó, J Linden, B Cronstein, P Pacher Nature reviews Drug discovery 7 (9), 759-770, 2008 | 1400 | 2008 |
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity D Osei-Hyiaman, M DePetrillo, P Pacher, J Liu, S Radaeva, S Bátkai, ... The Journal of clinical investigation 115 (5), 1298-1305, 2005 | 1348 | 2005 |
CD39 and CD73 in immunity and inflammation L Antonioli, P Pacher, ES Vizi, G Haskó Trends in molecular medicine 19 (6), 355-367, 2013 | 1268 | 2013 |
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential OV Evgenov, P Pacher, PM Schmidt, G Haskó, HHHW Schmidt, JP Stasch Nature reviews Drug discovery 5 (9), 755-768, 2006 | 908 | 2006 |
Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats P Pacher, T Nagayama, P Mukhopadhyay, S Bátkai, DA Kass Nature protocols 3 (9), 1422-1434, 2008 | 860 | 2008 |
Activation of the peripheral endocannabinoid system in human obesity S Engeli, J Bohnke, M Feldpausch, K Gorzelniak, J Janke, S Bátkai, ... Diabetes 54 (10), 2838-2843, 2005 | 834 | 2005 |
Immunity, inflammation and cancer: a leading role for adenosine L Antonioli, C Blandizzi, P Pacher, G Haskó Nature Reviews Cancer 13 (12), 842-857, 2013 | 819 | 2013 |
Endocannabinoid signaling at the periphery: 50 years after THC M Maccarrone, I Bab, T Bíró, GA Cabral, SK Dey, V Di Marzo, JC Konje, ... Trends in pharmacological sciences 36 (5), 277-296, 2015 | 763 | 2015 |
Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease JP Stasch, P Pacher, OV Evgenov Circulation 123 (20), 2263-2273, 2011 | 649 | 2011 |
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors N Agarwal, P Pacher, I Tegeder, F Amaya, CE Constantin, GJ Brenner, ... Nature neuroscience 10 (7), 870-879, 2007 | 649 | 2007 |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity M Bluher, S Engeli, N Kloting, J Berndt, M Fasshauer, S Bátkai, P Pacher, ... Diabetes 55 (11), 3053-3060, 2006 | 636 | 2006 |
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? P Pacher, V Kecskemeti Current pharmaceutical design 10 (20), 2463-2475, 2004 | 576 | 2004 |
Is lipid signaling through cannabinoid 2 receptors part of a protective system? P Pacher, R Mechoulam Progress in lipid research 50 (2), 193-211, 2011 | 543 | 2011 |
Evidence for novel cannabinoid receptors M Begg, P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, FM Mo, J Liu, ... Pharmacology & therapeutics 106 (2), 133-145, 2005 | 535 | 2005 |
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy M Rajesh, P Mukhopadhyay, S Bátkai, V Patel, K Saito, S Matsumoto, ... Journal of the American College of Cardiology 56 (25), 2115-2125, 2010 | 521 | 2010 |
Drug-induced mitochondrial dysfunction and cardiotoxicity ZV Varga, P Ferdinandy, L Liaudet, P Pacher American Journal of Physiology-Heart and Circulatory Physiology 309 (9 …, 2015 | 502 | 2015 |
Resveratrol induces mitochondrial biogenesis in endothelial cells A Csiszar, N Labinskyy, JT Pinto, P Ballabh, H Zhang, G Losonczy, ... American Journal of Physiology-Heart and Circulatory Physiology 297 (1), H13-H20, 2009 | 486 | 2009 |